药物基因组学关联研究的设计与实施
本文为教程性综述,面向受训者和新手研究者,概述开展药物基因组学关联研究需做出的关键决策:明确研究目的为发现、重复或验证,确定患者队列,选择并定义治疗结局(表型),决定基因分型方法与遗传数据,并采用统计方法检验基因型与表型的关联。
要点
- 首要决策是明确研究目的:发现、重复还是验证关联。
- 需选择具备所需全部数据的患者队列并定义治疗结局表型。
- 确定基因分型方法和遗传数据后,用统计方法检验关联。
核心结论
- 成功的药物基因组学关联研究是发现和验证遗传变异与治疗结局关联的必要条件,有助于临床转化以改善疗效和降低毒性。
研究设计与样本
- 本文为教程性综述,面向受训者和新手药物基因组学研究者的设计指导。
关键数值与推荐
- 研究目的分为发现、重复或验证。
- 需确定患者队列、选择并定义治疗结局(表型)、确定基因分型方法和遗传数据,并用统计方法检验关联。
临床怎么用
- 设计药物基因组学关联研究时,应依次明确研究目的、患者队列、表型定义、基因分型方法和统计分析方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacogenetics (PGx) association studies are used to discover, replicate, and validate the association between an inherited genotype and a treatment outcome. The objective of this tutorial is to provide trainees and novice PGx researchers with an overview of the major decisions that need to be made when designing and conducting a PGx association study. The first critical decision is to determine whether the objective of the study is discovery, replication, or validation. Next, the researcher must identify a patient cohort that has all of the data necessary to conduct the intended analysis. Then, the investigator must select and define the treatment outcome, or phenotype, that will be analyzed. Next, the investigator must determine what genotyping approach and genetic data will be included in the analysis. Finally, the association between the genotype and phenotype is tested using some statistical analysis methodology. This tutorial is divided into five sections; each section describes commonly used approaches and provides suggestions and resources for designing and conducting a PGx association study. Successful PGx association studies are necessary to discover and validate associations between inherited genetic variation and treatment outcomes, which enable clinical translation to improve efficacy and reduce toxicity of treatment.
引用
- Hertz DL, Arwood MJ, Stocco G, et al. Planning and Conducting a Pharmacogenetics Association Study. Clin Pharmacol Ther. 2021. PMID: 33880756. doi:10.1002/cpt.2270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。